Molecular mechanisms of arrhythmia caused by high-fat diet
高脂饮食引起心律失常的分子机制
基本信息
- 批准号:10316166
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-15 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:ArrhythmiaCRISPR/Cas technologyCalciumCardiacCardiac MyocytesDataDietElectrophysiology (science)Fatty AcidsFrequenciesFunctional disorderGenesGeneticGenetic ModelsGenetic TranscriptionHeartHigh Fat DietHumanInner mitochondrial membraneIntakeIon ChannelKnockout MiceLinkLipidsMethodsMitochondriaModelingMolecularMusNADPH OxidaseObesityOlive oil preparationOpticsOxidasesOxidative StressPathway interactionsRiskRodent ModelSarcoplasmic ReticulumSerumSignal TransductionTLR4 geneTestingTransgenic MiceVentricularVentricular FibrillationVentricular TachycardiaWild Type Mouseacetovanillonecalcium uniporterdiet-induced obesityexperimental studyheart rhythmhuman stem cellsin vivoinhibitorlipid metabolismmitochondrial dysfunctionmonounsaturated fatobese patientspreventsaturated fatsudden cardiac death
项目摘要
Obese patients have an increased risk of arrhythmias and twice the risk of sudden cardiac death, which
is often caused by ventricular tachycardias (VT). Cardiomyocytes from obese patients have increased lipid
content, which is thought to contribute to the pathophysiology of arrhythmia. Furthermore, higher levels of
serum fatty acids and higher saturated fat intake in the diet predict sudden cardiac death. This suggests that
the arrhythmogenic effects of saturated fat can occur without obesity. An unanswered question is: What are
the molecular mechanisms causing arrhythmias during obesity and high-fat diet?
The most common electrophysiologic abnormalities found in obese patients are increased frequency of
ventricular ectopy and prolongation of the QT interval. We have previously shown that wild type (WT) mice with
high-fat diet induced obesity (DIO) have long QT and increased ventricular ectopy, mimicking the abnormalities
found in obese humans. Our preliminary data now show that a high saturated fat diet is sufficient to cause
ventricular ectopy and prolong the QT interval, and to promote inducibility of VT/VF. Further, mice fed a diet
with an equivalent amount of monounsaturated fat from olive oil do not have heart rhythm abnormalities. We
discovered that a high saturated fat diet increases cardiac NAPDH oxidase 2 (NOX2) activity, whereas the
olive oil high-fat diet does not. The NOX2 inhibitor apocynin, when given during a high saturated fat diet,
prevents heart rhythm abnormalities. Additional experiments with isolated cardiac myocytes show that NOX2 is
necessary for the oxidative stress and mitochondrial dysfunction caused by saturated fat. We will use both in
vivo experiments and cardiomyocytes to determine the pathways linking cardiac lipid metabolism to
arrhythmia. Our central hypothesis is that NOX2 activation causes the arrhythmogenic effect of saturated fat
by causing sarcoplasmic reticulum calcium leak, which in turn promotes mitochondrial dysfunction.
We propose the following independent aims:
1. Determine if NOX2 activation causes arrhythmia during high fat diet, by using genetic gain and loss.
2. Determine how TLR4 signaling contributes to the arrhythmogenic effects of dietary saturated fat.
3. Determine if the mitochondrial abnormalities caused by NOX2 activation promote arrhythmia.
肥胖患者患心律失常的风险增加,是心脏猝死的风险的两倍,这是
通常是由心室心动过速(VT)引起的。肥胖患者的心肌细胞增加了脂质
含量,被认为有助于心律不齐的病理生理学。此外,较高的水平
饮食中的血清脂肪酸和较高的饱和脂肪摄入预测心脏死亡。这表明这一点
饱和脂肪的心律失常会发生,而无需肥胖。一个未解决的问题是:什么是
在肥胖和高脂饮食期间引起心律不齐的分子机制?
肥胖患者发现的最常见的电生理异常是
QT间隔的心室术和延长。我们以前已经证明了带有的野生型(WT)小鼠
高脂饮食诱导的肥胖症(DIO)的QT很长,心室均增加,模仿异常
在肥胖人类中发现。我们的初步数据现在表明,高饱和脂肪饮食足以引起
心室eCectopy并延长QT间隔,并促进VT/VF的诱导性。此外,小鼠饮食
来自橄榄油的同等含量脂肪的含量不具有心律异常。我们
发现高饱和脂肪饮食增加了心脏NAPDH氧化酶2(NOX2)活性,而
橄榄油高脂饮食没有。 NOX2抑制剂apocynin,在高饱和脂肪饮食期间给予
防止心律异常。孤立心肌细胞的其他实验表明NOX2是
对于由饱和脂肪引起的氧化应激和线粒体功能障碍所必需的。我们将两者都在
体内实验和心肌细胞,以确定将心脏脂质代谢联系起来的途径
心律不齐。我们的中心假设是NOX2激活会引起饱和脂肪的心律失常
通过引起肌质网钙泄漏,进而促进线粒体功能障碍。
我们提出以下独立目标:
1。通过使用遗传增益和损失,确定NOX2激活在高脂肪饮食期间是否引起心律不齐。
2。确定TLR4信号如何有助于饮食饱和脂肪的心律失常作用。
3。确定由NOX2激活引起的线粒体异常是否促进心律不齐。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanisms of Chronic Metabolic Stress in Arrhythmias.
- DOI:10.3390/antiox9101012
- 发表时间:2020-10-19
- 期刊:
- 影响因子:0
- 作者:Gowen BH;Reyes MV;Joseph LC;Morrow JP
- 通讯作者:Morrow JP
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome.
- DOI:10.1038/s44161-021-00016-2
- 发表时间:2022-03
- 期刊:
- 影响因子:0
- 作者:Song, LouJin;Bekdash, Ramsey;Morikawa, Kumi;Quejada, Jose R;Klein, Alison D;Aina-Badejo, Danielle;Yoshida, Kazushige;Yamamoto, Hannah E;Chalan, Amy;Yang, Risako;Patel, Achchhe;Sirabella, Dario;Lee, Teresa M;Joseph, Leroy C;Kawano, Fuun;Warren, Junco S;Soni, Rajesh K;Morrow, John P;Yazawa, Masayuki
- 通讯作者:Yazawa, Masayuki
Paracardial fat and vitamin A: a mechanism for regulating exercise performance.
心旁脂肪和维生素 A:调节运动表现的机制。
- DOI:10.1172/jci145969
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Joseph,LeroyC;Morrow,JohnP
- 通讯作者:Morrow,JohnP
Combined metabolomic and transcriptomic profiling approaches reveal the cardiac response to high-fat diet.
- DOI:10.1016/j.isci.2022.104184
- 发表时间:2022-05-20
- 期刊:
- 影响因子:5.8
- 作者:Joseph, Leroy C.;Shi, Jianting;Nguyen, Quynh N.;Pensiero, Victoria;Goulbourne, Chris;Bauer, Robert C.;Zhang, Hanrui;Morrow, John P.
- 通讯作者:Morrow, John P.
Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas: An Observational Study.
- DOI:10.1161/circep.120.009115
- 发表时间:2021-03
- 期刊:
- 影响因子:0
- 作者:Ostropolets A;Elias PA;Reyes MV;Wan EY;Pajvani UB;Hripcsak G;Morrow JP
- 通讯作者:Morrow JP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Pearce Morrow其他文献
John Pearce Morrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Pearce Morrow', 18)}}的其他基金
Molecular mechanisms of arrhythmia caused by high-fat diet
高脂饮食引起心律失常的分子机制
- 批准号:
10063888 - 财政年份:2018
- 资助金额:
$ 40万 - 项目类别:
Mechanisms of Ventricular Tachycardia in Lipotoxic Cardiomyopathy
脂毒性心肌病室性心动过速的机制
- 批准号:
8646980 - 财政年份:2011
- 资助金额:
$ 40万 - 项目类别:
Mechanisms of Ventricular Tachycardia in Lipotoxic Cardiomyopathy
脂毒性心肌病室性心动过速的机制
- 批准号:
8257120 - 财政年份:2011
- 资助金额:
$ 40万 - 项目类别:
Mechanisms of Ventricular Tachycardia in Lipotoxic Cardiomyopathy
脂毒性心肌病室性心动过速的机制
- 批准号:
8828277 - 财政年份:2011
- 资助金额:
$ 40万 - 项目类别:
Mechanisms of Ventricular Tachycardia in Lipotoxic Cardiomyopathy
脂毒性心肌病室性心动过速的机制
- 批准号:
8448188 - 财政年份:2011
- 资助金额:
$ 40万 - 项目类别:
Mechanisms of Ventricular Tachycardia in Lipotoxic Cardiomyopathy
脂毒性心肌病室性心动过速的机制
- 批准号:
8030628 - 财政年份:2011
- 资助金额:
$ 40万 - 项目类别:
相似国自然基金
基于CRISPR-Cas3系统靶向消减宿主背景的病原体高通量测序技术研究
- 批准号:32300080
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于柔性电极微电场的视网膜基因电转技术及其在CRISPR/Cas9基因编辑治疗遗传性视网膜疾病中的作用研究
- 批准号:82371075
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
结合CRISPR/Cas9技术调控肿瘤代谢重编程与氧化还原稳态的仿生纳米载药系统的构建及其HNSCC精准治疗研究
- 批准号:82304425
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于核酸预富集和CRISPR-Cas13a技术的新型梅毒核酸诊断和即时检测研究
- 批准号:82302579
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于CRISPR/Cas9-NHEJ基因编辑技术的致病型问号钩体跨人血管内皮层转运机制研究
- 批准号:82302545
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of VSNL1 in human heart rate regulation
VSNL1在人体心率调节中的作用
- 批准号:
10750747 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
High-throughput Flow Culture of 3D Human PKD Models for Therapeutic Screening
用于治疗筛选的 3D 人体 PKD 模型的高通量流式培养
- 批准号:
10649222 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
From Variants to Mechanisms for Cardiac Arrhythmias
从心律失常的变异到机制
- 批准号:
10719850 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
The Effects of Estrogen on Cardiac Arrhythmic Propensity
雌激素对心律失常倾向的影响
- 批准号:
10731400 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别: